Home » ETF » XBI

XBI - SPDR S&P Biotech ETF

Stock Price: $135.95 USD 3.18 (2.40%)
Updated Apr 22, 2021 12:11 PM EDT - Market open
Assets $6.89B
NAV $128.50
Expense Ratio 0.35%
PE Ratio 9.25
Beta (5Y) 1.30
Dividend (ttm) $0.32
Dividend Yield 0.25%
Ex-Dividend Date Mar 22, 2021
1-Year Return -
Trading Day April 22
Last Price $135.95
Previous Close $132.77
Change ($) 3.18
Change (%) 2.40%
Day's Open 132.43
Day's Range 130.81 - 136.86
Day's Volume 5,449,842
52-Week Range 89.24 - 174.74

Fund Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Asset Class
Equity
Sector
Biotech
Region
North America
Inception Date
Jan 31, 2006
Exchange
NYSEARCA
Ticker Symbol
XBI
Index Tracked
S&P Biotechnology Select Industry Index

Top 10 Holdings

8.18% of assets
NameSymbolWeight
United TherapeuticsUTHR0.94%
VericelVCEL0.83%
ModernaMRNA0.83%
AmgenAMGN0.82%
MacroGenicsMGNX0.81%
CytokineticsCYTK0.80%
Alexion PharmaceuticalsALXN0.80%
Dicerna PharmaceuticalsDRNA0.79%
Agios PharmaceuticalsAGIO0.78%
Gilead SciencesGILD0.78%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Mar 22, 2021$0.04Mar 25, 2021
Dec 21, 2020$0.176Dec 24, 2020
Sep 21, 2020$0.089Sep 24, 2020
Jun 22, 2020$0.017Jun 25, 2020
Dec 20, 2019$0.001Dec 26, 2019
Sep 20, 2019$0.003Sep 25, 2019
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Other tickers mentioned: AZN, BBH, BNTX, BTEC, FBT, IBB, MRNA ...
2 weeks ago - Zacks Investment Research

Biotechnology sector-related exchange traded funds could stumble in the near-term as increased regulatory scrutiny weighs on drugmakers. Among the hardest hit areas of Tuesday, the ALPS Medical Breakthr...

Other tickers mentioned: IBB, SBIO
4 weeks ago - ETF Trends

Biotech is ‘the superhero of the pandemic': investor

YouTube video

Antoine Papiernik, managing partner at Sofinnova Partners, joins Yahoo Finance to discuss trends in biotech and impacts the pandemic had on scientific discoveries.

Other tickers mentioned: IBB
4 weeks ago - Yahoo Finance

Short-term investors may not see the long-term potential.

Other tickers mentioned: IBB, NVAX, OCGN, VIR
1 month ago - The Motley Fool

They've both already made some investors a lot of money over the last few years.

Other tickers mentioned: ARKK
1 month ago - The Motley Fool

Stocks: Biotech and the outlook for vaccine stocks over the next 3-5 years

YouTube video

Yahoo Finance's Julie Hyman and Myles Udland spoke to Oppenheimer & Co. Analyst Hartaj Singh about the outlook for vaccine stocks.

Other tickers mentioned: IBB
1 month ago - Yahoo Finance

Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.

Other tickers mentioned: BOTZ, CLIX, CLOU, FMAT, IBB, IBUY, JNJ ...
1 month ago - Zacks Investment Research

Given the jump in investors' sentiment, ETFs that still trade at bargain price seem excellent pick.

Other tickers mentioned: DEEP, FDM, IAK, IEO, SDIV
1 month ago - Zacks Investment Research

Investing in Biotech is a Long Game: Schulman

YouTube video

Feb.26 -- Polaris Partners Managing Partner Amy Schulman says that the key to investing in biotech is to diversify by investing in a portfolio. She cautions that biotech investments can be risky, but sa...

1 month ago - Bloomberg Markets and Finance

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high.

Other tickers mentioned: BSX, IBB
2 months ago - InvestorPlace

Interest rates hit their highest levels in a year on Wednesday, putting pressure on long-duration assets.

Other tickers mentioned: ARKK, HYG, IEF, LQD, QQQ, TLT
2 months ago - ETFcom

These 13 growth ETFs allow investors to strive for hotter returns without overexposing themselves to one or two high-risk stocks.

Other tickers mentioned: ARKF, EFG, FXI, IBUY, IWP, NXTG, PBW ...
2 months ago - Kiplinger

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

Other tickers mentioned: BBH, IBB
2 months ago - Zacks Investment Research

Biotech sector will continue to see activity: Margie Patel

YouTube video

Andy Kapyrin, Regent Atlantic director of research, and Margie Patel, Wells Fargo Asset Management senior portfolio manager and managing director, join CNBC's "The Exchange" to discuss the current infla...

2 months ago - CNBC Television

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

Other tickers mentioned: ARKG, IDNA
2 months ago - Investopedia

Should investors watch for a squeeze?

Other tickers mentioned: XOP, XRT
2 months ago - The Motley Fool

It's a big bet but not a big gamble.

Other tickers mentioned: EDIT, GH, ISRG, TDOC, VRTX
2 months ago - The Motley Fool

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

Other tickers mentioned: ARKG, BBH, BNTX, BTEC, CNCR, FBT, IBB ...
3 months ago - Zacks Investment Research

We highlight some ETF areas that held their ground and gained popularity among investors amid the coronavirus crisis.

Other tickers mentioned: CLIX, CLOU, ESGU, ESPO, HERO, IBB, IBUY ...
3 months ago - Zacks Investment Research

After a lull in mergers and acquisitions activity, Big Pharma could begin to use its cash stores to buy out smaller targets, potentially fueling the momentum in biotechnology-related exchange traded fun...

Other tickers mentioned: IBBJ, SBIO
3 months ago - ETF Trends

Biotech remains a strong opportunity for 2021, says Jefferies' Michael Yee

YouTube video

Michael Yee, Jefferies managing director, joins CNBC's "Closing Bell" to discuss the biotech sector's busy year, with companies such as Moderna racing to complete a Covid-19 vaccine and others looking f...

3 months ago - CNBC Television

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

Other tickers mentioned: ARKG, BTEC, GNOM, IDNA
3 months ago - Zacks Investment Research

Stimulus deal appears to set the stage for the Santa rally in 2020.

Other tickers mentioned: IAI, RYT, VIOO, XRT
3 months ago - Zacks Investment Research

The Christmas tree of top-ranked ETFs to brighten 2021 is now ready for investors. May it spread cheer!

Other tickers mentioned: ARKW, TAN, VTV, XLI, XRT, XSMO
3 months ago - Zacks Investment Research

The coronavirus outbreak notwithstanding, 2020 has been shaping up as a blockbuster year.

Other tickers mentioned: JKH, PTF, QQQ, SOCL, TAN, VCR, WCLD ...
4 months ago - Zacks Investment Research

Why this health-care strategist says the sector will rally into 2021

YouTube video

CNBC's Kelly Evans discusses the healthcare sector as well as biotech and pharma stocks and why the rally in these names can continue into 2021 with Jefferies' Jared Holz.

Other tickers mentioned: IBB
4 months ago - CNBC Television

These ETFs have emerged as one of the top performers in the past decade.

Other tickers mentioned: DIA, IHI, PNQI, PSCH, QQQ, SOXX, SPY ...
4 months ago - Zacks Investment Research

These ETFs have emerged as one of the top performers in the past decade.

Other tickers mentioned: FPX, IHI, IWY, PNQI, PSCH, SOXX, VCR ...
4 months ago - Zacks Investment Research

Index funds offer investors the opportunity for diversified growth. With the S&P 500 and Dow Jones up so much in 2020, here are 7 others.

Other tickers mentioned: FM, IJS, MCHI, RYT, VXUS, EFAD
4 months ago - InvestorPlace

Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K. bec...

Other tickers mentioned: CNCR, IBB
4 months ago - ETF Trends

November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday, pharm...

Other tickers mentioned: BBH, IBB
4 months ago - ETF Trends

The biotech ETF hits a 52-week high on Nov 27. Can it soar further?

4 months ago - Zacks Investment Research

The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.

Other tickers mentioned: CARZ, FBT, IBB, JETS, KBWB, KRE, PEJ ...
4 months ago - Zacks Investment Research

Biotech companies need capital, but challenge is finding high quality management teams: Cowen CEO

YouTube video

On Monday, Pfizer announced a successful phase 3 trial, showing the vaccine to be more than 90 percent effective. This comes as the FDA gave emergency use authorization to Eli Lilly's antibody treatment.

Other tickers mentioned: IBB
5 months ago - CNBC Television

Though the election results are yet to become official, many sectors are expected to benefit on Biden's potential victory.

Other tickers mentioned: ACES, CARZ, GLD, GLDM, IAU, ICLN, ITB ...
5 months ago - Zacks Investment Research

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

Other tickers mentioned: IBB, PJP, PPH, VHT, XLV
5 months ago - Zacks Investment Research

Wall Street booked remarkable gains a day after the election on hopes of a divided Congress.

Other tickers mentioned: EMQQ, KWEB, PBE, RWGV, WCLD
5 months ago - Zacks Investment Research

This biotech ETF has hit a new 52-week high. Are more gains in store?

5 months ago - Zacks Investment Research

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their third-quarter earnings releases amid the coronavirus crisis.

Other tickers mentioned: BBH, IBB
5 months ago - Zacks Investment Research

As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds, ...

Other tickers mentioned: ARKG, BBH, FBT
5 months ago - ETF Trends

How the presidential election could impact your portfolio

Other tickers mentioned: CNRG, TAN, XHB, XHE
5 months ago - Zacks Investment Research

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

Other tickers mentioned: ARKG, BBH, IBB, PBE
6 months ago - Zacks Investment Research

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

Other tickers mentioned: ARKG, BBH, IBB, PBE
6 months ago - Zacks Investment Research

These funds could be the best ways for investors to tap the opportunity arising from the Bristol Myers-MyoKardia deal and will likely see smooth trading in the months to come.

Other tickers mentioned: ARKG, BBC, SBIO, XPH
6 months ago - Zacks Investment Research

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

Other tickers mentioned: ARKG, BBH, IBB
6 months ago - Zacks Investment Research

Buying 140 biotech stocks in one fell swoop could be a winning strategy.

6 months ago - The Motley Fool

Biotech Sector Chart The broad stock market’s two day rally saw biotech stocks surge higher. In particular, the reversal in Biotech Sector ETFs BBH and XBI looks to be bullish.

Other tickers mentioned: BBH
6 months ago - See It Market

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

Other tickers mentioned: ARKG, BBH, FBT, IBB
6 months ago - Zacks Investment Research

Here are a bunch of exchange-traded funds with above-average growth rates. See which ones most inspire your confidence.

Other tickers mentioned: FTEC, IHI, IVW, IWF, NUMG, PTH, QQQ ...
6 months ago - The Motley Fool

Justice Ruth Bader Ginsburg's death jeopardizes Obamacare's future, and that puts healthcare companies' revenue at risk.

Other tickers mentioned: CNC, HCA, XLV
7 months ago - The Motley Fool